Inari Medical Cash on Hand 2019-2024 | NARI
Inari Medical cash on hand from 2019 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Inari Medical Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $116 |
| 2022 | $326 |
| 2021 | $176 |
| 2020 | $164 |
| 2019 | $24 |
| 2018 | $ |
| Inari Medical Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-06-30 | $110 |
| 2024-03-31 | $102 |
| 2023-12-31 | $116 |
| 2023-09-30 | $351 |
| 2023-06-30 | $338 |
| 2023-03-31 | $328 |
| 2022-12-31 | $326 |
| 2022-09-30 | $319 |
| 2022-06-30 | $330 |
| 2022-03-31 | $339 |
| 2021-12-31 | $176 |
| 2021-09-30 | $163 |
| 2021-06-30 | $176 |
| 2021-03-31 | $174 |
| 2020-12-31 | $164 |
| 2020-09-30 | $168 |
| 2020-06-30 | $195 |
| 2020-03-31 | |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.587B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $225.969B | 27.09 |
| Intuitive Surgical (ISRG) | United States | $169.358B | 95.89 |
| Alcon (ALC) | Switzerland | $47.001B | 33.09 |
| IQVIA Holdings (IQV) | United States | $42.487B | 24.08 |
| Edwards Lifesciences (EW) | United States | $41.144B | 26.37 |
| IDEXX Laboratories (IDXX) | United States | $38.181B | 45.93 |
| DexCom (DXCM) | United States | $28.011B | 39.94 |
| STERIS (STE) | Ireland | $22.286B | 26.01 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.936B | 0.00 |
| Waters (WAT) | United States | $21.012B | 31.33 |
| Hologic (HOLX) | United States | $19.032B | 20.69 |
| Sysmex ADR (SSMXY) | Japan | $11.883B | 37.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.754B | 13.18 |
| Teleflex (TFX) | United States | $11.078B | 17.23 |
| Globus Medical (GMED) | United States | $10.139B | 28.36 |
| Penumbra (PEN) | United States | $7.980B | 82.83 |
| Masimo (MASI) | United States | $7.690B | 41.19 |
| Glaukos (GKOS) | United States | $7.045B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.395B | 25.70 |
| TransMedics (TMDX) | United States | $4.336B | 185.67 |
| PROCEPT BioRobotics (PRCT) | United States | $3.763B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.888B | 16.94 |
| Nihon Kohden (NHNKY) | Japan | $2.746B | 17.08 |
| Veracyte (VCYT) | United States | $2.667B | 165.33 |
| Elekta AB (EKTAY) | Sweden | $2.589B | 21.09 |
| Tandem Diabetes Care (TNDM) | United States | $2.455B | 0.00 |
| RxSight (RXST) | United States | $1.874B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.536B | 7.00 |
| Artivion (AORT) | United States | $1.127B | 103.42 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.053B | 18.79 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.808B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| OrthoPediatrics (KIDS) | United States | $0.672B | 0.00 |
| IRadimed (IRMD) | United States | $0.653B | 35.31 |
| AxoGen (AXGN) | United States | $0.634B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.612B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.561B | 0.00 |
| SiBone (SIBN) | United States | $0.551B | 0.00 |
| Paragon 28 (FNA) | United States | $0.487B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.342B | 10.42 |
| Treace Medical Concepts (TMCI) | United States | $0.334B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.331B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.303B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.264B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.253B | 0.00 |
| Inogen (INGN) | United States | $0.222B | 0.00 |
| Accuray (ARAY) | United States | $0.191B | 0.00 |
| Nevro (NVRO) | United States | $0.189B | 0.00 |
| NeuroPace (NPCE) | United States | $0.188B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.188B | 13.15 |
| Atossa Genetics (ATOS) | United States | $0.185B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| 908 Devices (MASS) | United States | $0.122B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.122B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.118B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.112B | 16.63 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
| LENSAR (LNSR) | United States | $0.065B | 0.00 |
| InspireMD (NSPR) | Israel | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Neuronetics (STIM) | United States | $0.028B | 0.00 |
| Precision Optics (POCI) | United States | $0.028B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.024B | 0.00 |
| Spectral AI (MDAI) | United States | $0.023B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |